Lv1
30 积分 2021-12-08 加入
[Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases]
7个月前
已完结
[Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion]
7个月前
已完结
Novel therapeutic strategies targeting bypass pathways and mitochondrial dysfunction to combat resistance to RET inhibitors in NSCLC
7个月前
已完结
Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities
7个月前
已关闭
The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
7个月前
已完结
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival
8个月前
已完结
SMARCA4-deficient central nervous system metastases: A case series and systematic review
8个月前
已完结
Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer
1年前
已完结
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer
1年前
已完结
Phase I dose escalation and pharmacokinetic study on the nanoparticle formulation of polymeric micellar paclitaxel for injection in patients with advanced solid malignancies
1年前
已完结
皖公网安备34019202002308
